Filing Details

Accession Number:
0001628280-19-011197
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-26 19:45:28
Reporting Period:
2019-08-22
Accepted Time:
2019-08-26 19:45:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576280 Guardant Health Inc. GH Services-Medical Laboratories (8071) 454139254
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753159 Amirali Talasaz 505 Penobscot Drive
Redwood City CA 94063
Chairman, President And Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-23 1,596 $98.78 1,965 No 4 S Direct
Common Stock Disposition 2019-08-23 462 $99.24 1,503 No 4 S Direct
Common Stock Disposition 2019-08-23 6,281 $94.79 3,635,507 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-23 6,561 $95.53 3,628,946 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-23 3,103 $96.76 3,625,843 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-23 3,328 $97.72 3,622,515 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-23 4,489 $98.78 3,618,026 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-23 1,294 $99.24 3,616,732 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-23 170 $94.80 10,385 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 177 $95.52 10,208 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 81 $96.80 10,127 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 91 $97.71 10,036 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 125 $98.77 9,911 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 31 $99.24 9,880 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 170 $94.80 10,386 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 177 $95.52 10,209 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 82 $96.80 10,127 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 91 $97.71 10,036 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 125 $98.77 9,911 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Disposition 2019-08-23 31 $99.24 9,880 No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock Acquisiton 2019-08-26 4,721 $4.18 6,224 No 4 M Direct
Common Stock Disposition 2019-08-26 1,267 $92.26 4,957 No 4 S Direct
Common Stock Disposition 2019-08-26 1,714 $93.12 3,243 No 4 S Direct
Common Stock Disposition 2019-08-26 1,288 $94.14 1,955 No 4 S Direct
Common Stock Disposition 2019-08-26 501 $94.87 1,454 No 4 S Direct
Common Stock Disposition 2019-08-26 3,553 $92.26 3,613,179 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-26 4,767 $93.12 3,608,412 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-26 3,613 $94.14 3,604,799 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-26 1,403 $94.87 3,603,396 No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock Disposition 2019-08-26 96 $92.27 9,784 No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 S Indirect Shares held by Sana Talasaz 2018 Irrevocable Trust
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Talasaz and Eskandari 2017 Family Trust
No 4 S Indirect Shares held by Samar Talasaz 2018 Irrevocable Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2019-08-26 4,721 $0.00 4,721 $4.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,081,850 2022-07-13 No 4 M Direct
Footnotes
  1. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.17 to $99.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.17 to $99.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.12 to $95.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.12 to $96.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.15 to $97.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.16 to $98.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.60 to $92.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.60 to $93.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.60 to $94.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  12. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.60 to $95.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  13. The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.